Premera Blue Cross prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
Premera Blue Cross reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers Premera Blue Cross's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Premera Blue Cross →
- Aflibercept at Premera Blue Cross →
- Apixaban at Premera Blue Cross →
- Atezolizumab at Premera Blue Cross →
- Atogepant at Premera Blue Cross →
- Benralizumab at Premera Blue Cross →
- Bevacizumab at Premera Blue Cross →
- Bictegravir at Premera Blue Cross →
- Buprenorphine at Premera Blue Cross →
- Dapagliflozin at Premera Blue Cross →
- Dulaglutide at Premera Blue Cross →
- Dupilumab at Premera Blue Cross →
- Eculizumab at Premera Blue Cross →
- Elexacaftor Tezacaftor Ivacaftor at Premera Blue Cross →
- Empagliflozin at Premera Blue Cross →
- Erenumab at Premera Blue Cross →
- Evolocumab at Premera Blue Cross →
- Faricimab at Premera Blue Cross →
- Fingolimod at Premera Blue Cross →
- Fremanezumab at Premera Blue Cross →
- Galcanezumab at Premera Blue Cross →
- Glecaprevir Pibrentasvir at Premera Blue Cross →
- Guselkumab at Premera Blue Cross →
- Ibrutinib at Premera Blue Cross →
- Imatinib at Premera Blue Cross →
- Inclisiran at Premera Blue Cross →
- Infliximab at Premera Blue Cross →
- Ixekizumab at Premera Blue Cross →
- Lenalidomide at Premera Blue Cross →
- Liraglutide at Premera Blue Cross →
- Lisdexamfetamine at Premera Blue Cross →
- Mepolizumab at Premera Blue Cross →
- Methylphenidate at Premera Blue Cross →
- Naltrexone at Premera Blue Cross →
- Natalizumab at Premera Blue Cross →
- Nintedanib at Premera Blue Cross →
- Nivolumab at Premera Blue Cross →
- Nusinersen at Premera Blue Cross →
- Ocrelizumab at Premera Blue Cross →
- Ofatumumab at Premera Blue Cross →
- Omalizumab at Premera Blue Cross →
- Ozanimod at Premera Blue Cross →
- Palbociclib at Premera Blue Cross →
- Pembrolizumab at Premera Blue Cross →
- Pirfenidone at Premera Blue Cross →
- Ribociclib at Premera Blue Cross →
- Rimegepant at Premera Blue Cross →
- Risankizumab at Premera Blue Cross →
- Rituximab at Premera Blue Cross →
- Rivaroxaban at Premera Blue Cross →
- Sacubitril Valsartan at Premera Blue Cross →
- Secukinumab at Premera Blue Cross →
- Semaglutide at Premera Blue Cross →
- Sofosbuvir at Premera Blue Cross →
- Tafamidis at Premera Blue Cross →
- Tenofovir Alafenamide at Premera Blue Cross →
- Tezepelumab at Premera Blue Cross →
- Tirzepatide at Premera Blue Cross →
- Tofacitinib at Premera Blue Cross →
- Trastuzumab at Premera Blue Cross →
- Upadacitinib at Premera Blue Cross →
- Ustekinumab at Premera Blue Cross →
Generate a Premera Blue Cross PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Premera Blue Cross's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com